Free Trial

Vor Biopharma (VOR) SEC Filings & 10K Form

Vor Biopharma logo
$2.09 -0.09 (-4.13%)
Closing price 08/6/2025 04:00 PM Eastern
Extended Trading
$2.15 +0.06 (+2.87%)
As of 08/6/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vor Biopharma SEC Filings

DateFilerForm TypeView
08/06/2025
11:19 AM
FMR LLC (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form SCHEDULE 13G/A
08/04/2025
5:08 PM
Lundberg Sven Ante (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2025
4:01 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
4:11 PM
Cumbo Alexander (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2025
4:12 PM
Detheux Michel (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2025
4:14 PM
Cumbo Alexander (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2025
4:16 PM
Detheux Michel (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025
3:07 PM
ANG ROBERT (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2025
4:29 PM
ANG ROBERT (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2025
3:22 PM
ANG ROBERT (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
4:00 PM
5AM Ventures VI, L.P. (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form SCHEDULE 13D/A
07/02/2025
3:40 PM
ANG ROBERT (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2025
4:15 PM
ANG ROBERT (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2025
8:18 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
4:45 PM
Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Patterson Matthew R (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Beckman Daniella (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Lubner David Charles (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Lundberg Sven Ante (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Resnick Joshua (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:47 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:35 AM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2025
3:30 PM
Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
11:15 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form EFFECT
03/28/2025
3:33 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form PRE 14A
03/20/2025
3:45 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2025
3:48 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
3:01 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
3:29 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:34 AM
FMR LLC (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form SCHEDULE 13G/A
02/07/2025
3:35 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:36 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:37 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:01 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
8:19 PM
Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:20 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:22 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:23 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
11:15 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form EFFECT
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the September 1st funding windo
01/29/2025
4:24 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 424B3
01/21/2025
3:24 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2025
5:39 PM
Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:41 PM
Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
8:06 AM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:53 PM
Reprogrammed Interchange LLC (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form SCHEDULE 13D
01/02/2025
6:37 PM
Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
6:42 PM
Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:15 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
5:51 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form SCHEDULE 13D/A
12/30/2024
5:52 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:17 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2024
8:05 AM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
6:39 AM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:33 PM
Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
Form SC 13G/A
11/08/2024
3:15 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:15 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:15 PM
Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:20 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
3:16 PM
Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
3:17 PM
Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:05 AM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:06 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:01 PM
Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:29 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:30 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:VOR) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners